WASHINGTON, D.C. (August 19, 2021)—Stakeholders representing health care providers and end users with medical needs developed a white paper to educate payers and state Medicaid programs on the types of products and services needed to successfully manage an individual’s bowel and bladder needs in a home-based setting to achieve the Triple Aim of improving patient experience and health outcomes while reducing overall cost. 
 

WASHINGTON, D.C. (April 9, 2021)—For a short period early in the COVID-19 pandemic, the Centers for Medicare & Medicaid Services (CMS) expanded its Accelerated and Advanced Payments (AAP) Program to Medicare providers and suppliers, including DME and home health suppliers. The expanded program was available for suppliers starting March 28, 2020, and the suspension of the program was announced a month later in April.

WASHINGTON, D.C. (March 5, 2021)—The National Association for Home Care & Hospice (NAHC) has joined with a group of like-minded groups in the Leadership Council of Aging Organizations (LCAO) in urging Congress to protect vital programs like Medicare and Social Security from steep and unnecessary spending cuts that could cause considerable harm to America’s elderly and disabled populations.

WASHINGTON, D.C. (December 4, 2020)—Reps. Brad Schneider (D-Illinois) and David McKinley (R-West Virginia ) have introduced legislation to prevent Medicare reimbursement cuts to health care providers through the duration of the COVID-19 public health emergency. The Medicare Sequester COVID Moratorium Act (H.R. 8840) would continue a pause of 2% Medicare sequester cuts through the duration of the public health emergency. In March, Congress halted the 2% sequester cuts through Dec.

BIRMINGHAM, Ala. (December 3, 2020)—The United States Department of Justice (DOJ) recently released updates on its ongoing efforts to combat health care fraud and abuse by publishing the results of its 2020 takedown effort targeting, among others, fraud and abuse in the telemedicine and prescription drug industries (2020 Takedown).

WASHINGTON, D.C. (November 13, 2020)—The Centers for Medicare & Medicaid Services (CMS) announced that Medicare beneficiaries can receive coverage of monoclonal antibodies to treat coronavirus disease 2019 (COVID-19) with no cost-sharing during the public health emergency (PHE). CMS’s coverage of monoclonal antibody infusions applies to bamlanivimab, which received an emergency use authorization (EUA) from the U.S. Food and Drug Administration on Nov. 9.